Customize your JAMA Network experience by selecting one or more topics from the list below.
The 2003 Conley Ethics Essay competition asked medical students to consider
the competing interests of a mother and daughter faced with the mother's Huntington
disease (HD), a genetic disorder that causes relentless neurological decline
and that is 100% penetrant in carriers of the gene. The mother, however, refuses
to discuss her diagnosis with her daughter because she does not wish to burden
her. The daughter is considering starting a family and knows nothing about
the family history of HD. This issue of MSJAMA presents the essays by the winners of this year's contest, Andrew
Garrison and Courtney Wusthoff. They attempt to outline approaches to the
problem that uphold ethical standards while providing the best care possible
to both patients.
Although both authors ultimately argue that the mother's genetic information
should not be disclosed to the daughter, Wusthoff and Garrison diverge in
the rationales for their arguments as well as their approaches to finding
an acceptable remedy for the situation. Garrison examines the ways that ethical
consensus and case law can be used to shed light on the issue. Wusthoff, on
the other hand, emphasizes the psychological and social aspects of genetic
testing, arguing that what appears to be an intractable ethical dilemma may
actually be a part of the mother's coping process that will resolve itself
Both authors choose to base their arguments in some part on guidelines
put forth by committees from the American Society for Human Genetics and the
Institute of Medicine, both of which follow the position of the President's
Commission for the Study of Ethical Problems in Medicine and Biomedical and
Behavioral Research. These bodies take the position that disclosure of genetic
results is sometimes permissible under specific conditions: when attempts
to encourage the patient to disclose his or her results have failed, and serious
harm to the relative can be anticipated; when the at-risk relative can be
identified; and when the information disclosed can be used to prevent or treat
the disease in the relative. This framework provides a useful approach to
the question, but as both authors show, determining who is at risk, how they
might be harmed, and what "treatment" of a condition entails can be murkier
than might appear at first glance.
Although most clinicians are unlikely to come across a scenario like
the one presented here, the issues it raises are more universal: When is it
permissible to act against the wishes of a patient to promote his or her best
interest? When do the interests of others outweigh the rights of one person?
These are questions that emerge with some frequency in clinical settings.
These essays represent 2 approaches to these questions, attempting to find
ethical solutions to the problem that also promote a good clinical relationship.
Acknowledgment: We thank our judges for this
year: George Annas, Mark Schechter, and Jeffrey Botkin.
Ihler E. Genetic Information and Competing Interests. JAMA. 2003;290(9):1216. doi:10.1001/jama.290.9.1216-a
Coronavirus Resource Center
Create a personal account or sign in to: